The North America Defibrillators Market attained a market size of $ 11,304.8 Million in 2015 and is expected to grow at a CAGR of 6.6 % CAGR during 2016 - 2022. The US market dominated the North America Defibrillators market in 2015 and would continue till 2022, growing at a CAGR of 4.3 % during the forecast period. The Canada market is expected to reach a market size of $ 1,029.1 Million by 2022. The Mexico market would witness the high growth rate of 7.8 % during 2016-2022. The North America Advanced Life Support (ALS) Defibrillators Market attained a market size of $ 981.8 Million in 2015 and is expected to grow at a CAGR of 4.1 % CAGR during 2016 - 2022.
The US market dominated the North America Wearable Defibrillators Market in 2015 and would continue till 2022 thereby achieving a market value of $ 361.0 Million by 2022 growing at a CAGR of 3.2 % during the forecast period. The Hospitals segment dominated the North America Defibrillators market and attained a market size of $ 3,566.7 Million in 2015. The Pre-hospitals segment would attain a market size of $140.8 Million by 2022.
The Public Access Markets segment would grow at a CAGR of 8.2 % during the forecast period. The report provides a comprehensive analysis of the key players operating in the world defibrillators market, such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
Full report: https://www.kbvresearch.com/north-america-defibrillators-market/
The market is segmented based on product type, end use and country.
Related Reports: